Literature DB >> 15647649

Long-term results of endoscopic drainage of common bile duct strictures in chronic pancreatitis.

Djuna L Cahen1, Anne-Marie M van Berkel, Daphne Oskam, Erik A J Rauws, Gerrit Jan Weverling, Kees Huibregtse, Marco J Bruno.   

Abstract

OBJECTIVES: Endoscopic stent therapy is an established treatment modality for postoperative biliary strictures. At present, biliary stenting is also widely applied in chronic pancreatitis (CP), but results regarding long-term outcome are scarce.
METHODS: All CP patients who underwent endoscopic biliary drainage of a benign stricture in our hospital between 1987 and 2000 were included in this retrospective study.
RESULTS: Fifty-eight CP patients underwent biliary stenting (median age, 54 years; 44 male). The procedure-related mortality rate was 2% and the complication rate 4%. Median follow-up was 45 months (range, 0-182 months). Endoscopic treatment was successful in 22 patients (38%). Concomitant acute pancreatitis was the only factor identified as predictive of a successful outcome by multivariate analyses. Subanalysis of these 12 patients revealed a success rate of 92%, as opposed to 24% in cases without acute inflammation. In this latter group, continued stenting beyond a 1-year period almost never resulted in additional stricture resolvement. If stricture resolution was accomplished, however, no recurrences were observed.
CONCLUSIONS: For biliary strictures due to CP, without evidence of concomitant acute pancreatitis, the long-term success rate of endoscopic therapy is poor and only one out of four strictures is treated successfully. When a biliary stricture has not resolved after 1 year of endoscopic stenting, surgery should be considered.

Entities:  

Mesh:

Year:  2005        PMID: 15647649     DOI: 10.1097/00042737-200501000-00019

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  26 in total

1.  A New Fully Covered Self-Expandable Metal Stent for the Treatment of Postsurgical Benign Biliary Strictures.

Authors:  Jun Wu; Dong-Xun Zhou; Tian-Tian Wang; Dao-Jian Gao; Bing Hu
Journal:  Dig Dis Sci       Date:  2017-08-03       Impact factor: 3.199

2.  Surgical Management of Benign Biliary Stricture in Chronic Pancreatitis: A Single-Center Experience.

Authors:  Sukanta Ray; Supriyo Ghatak; Khaunish Das; Jayanta Dasgupta; Sujay Ray; Sujan Khamrui; Pankaj Kumar Sonar; Somak Das
Journal:  Indian J Surg       Date:  2013-07-11       Impact factor: 0.656

3.  What is the role of endotherapy in chronic pancreatitis?

Authors:  Haritha Avula; Stuart Sherman
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

4.  Benign biliary strictures related to chronic pancreatitis: balloons, stents, or surgery.

Authors:  Sami Arslanlar; Rajeev Jain
Journal:  Curr Treat Options Gastroenterol       Date:  2007-10

Review 5.  Endoscopic therapy of benign biliary strictures.

Authors:  Joel R Judah; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

Review 6.  Benign biliary strictures: current endoscopic management.

Authors:  Sergio Zepeda-Gómez; Todd H Baron
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-09-06       Impact factor: 46.802

Review 7.  Endoscopic management of benign biliary strictures.

Authors:  Tarun Rustagi; Priya A Jamidar
Journal:  Curr Gastroenterol Rep       Date:  2015-01

Review 8.  Endoscopic therapy for chronic pancreatitis: an evidence-based review.

Authors:  C Mel Wilcox; Shyam Varadarajulu
Journal:  Curr Gastroenterol Rep       Date:  2006-04

Review 9.  Endoscopic therapy for chronic pancreatitis: technical success, clinical outcomes, and complications.

Authors:  Lukasz M Kowalczyk; Peter V Draganov
Journal:  Curr Gastroenterol Rep       Date:  2009-04

Review 10.  Plastic or metal stents for benign extrahepatic biliary strictures: a systematic review.

Authors:  Petra G A van Boeckel; Frank P Vleggaar; Peter D Siersema
Journal:  BMC Gastroenterol       Date:  2009-12-17       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.